These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38902121)

  • 41. A comparison of magnetic resonance imaging techniques used to secure biopsies in prostate cancer patients.
    van Luijtelaar A; Bomers J; Fütterer J
    Expert Rev Anticancer Ther; 2019 Aug; 19(8):705-716. PubMed ID: 31277551
    [No Abstract]   [Full Text] [Related]  

  • 42. Micro-Ultrasound-Guided vs Multiparametric Magnetic Resonance Imaging-Targeted Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-Analysis.
    Sountoulides P; Pyrgidis N; Polyzos SA; Mykoniatis I; Asouhidou E; Papatsoris A; Dellis A; Anastasiadis A; Lusuardi L; Hatzichristou D
    J Urol; 2021 May; 205(5):1254-1262. PubMed ID: 33577367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
    Recabal P; Assel M; Sjoberg DD; Lee D; Laudone VP; Touijer K; Eastham JA; Vargas HA; Coleman J; Ehdaie B
    J Urol; 2016 Aug; 196(2):374-81. PubMed ID: 26920465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR.
    Rosenkrantz AB; Verma S; Choyke P; Eberhardt SC; Eggener SE; Gaitonde K; Haider MA; Margolis DJ; Marks LS; Pinto P; Sonn GA; Taneja SS
    J Urol; 2016 Dec; 196(6):1613-1618. PubMed ID: 27320841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are Magnetic Resonance Imaging-Transrectal Ultrasound Guided Targeted Biopsies Noninferior to Transrectal Ultrasound Guided Systematic Biopsies for the Detection of Prostate Cancer?
    Delongchamps NB; Portalez D; Bruguière E; Rouvière O; Malavaud B; Mozer P; Fiard G; Cornud F;
    J Urol; 2016 Oct; 196(4):1069-75. PubMed ID: 27079582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic Resonance Imaging Targeted Biopsy Improves Selection of Patients Considered for Active Surveillance for Clinically Low Risk Prostate Cancer Based on Systematic Biopsies.
    Ouzzane A; Renard-Penna R; Marliere F; Mozer P; Olivier J; Barkatz J; Puech P; Villers A
    J Urol; 2015 Aug; 194(2):350-6. PubMed ID: 25747105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection rate of clinically significant prostate cancer in magnetic resonance imaging and ultrasonography-fusion transperineal targeted biopsy for lesions with a prostate imaging reporting and data system version 2 score of 3-5.
    Hakozaki Y; Matsushima H; Murata T; Masuda T; Hirai Y; Oda M; Kawauchi N; Yokoyama M; Kume H
    Int J Urol; 2019 Feb; 26(2):217-222. PubMed ID: 30461076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of Initial Experience with Transrectal Magnetic Resonance Imaging Cognitive Guided Micro-Ultrasound Biopsies versus Established Transperineal Robotic Ultrasound Magnetic Resonance Imaging Fusion Biopsies for Prostate Cancer.
    Claros OR; Tourinho-Barbosa RR; Fregeville A; Gallardo AC; Muttin F; Carneiro A; Stabile A; Moschini M; Macek P; Cathala N; Mombet A; Sanchez-Salas R; Cathelineau X
    J Urol; 2020 May; 203(5):918-925. PubMed ID: 31821099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Lesion Location on Prostate Cancer Detection Rate with Magnetic Resonance Imaging Targeted Biopsy in African Americans.
    Walton E; Yaguchi G; Keeley J; Deebajah M; Menon M; Peabody J; Dabaja A; Alanee S
    J Urol; 2019 Mar; 201(3):503-509. PubMed ID: 30316896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis.
    Uleri A; Baboudjian M; Tedde A; Gallioli A; Long-Depaquit T; Palou J; Basile G; Gaya JM; Sanguedolce F; Lughezzani G; Rajwa P; Pradere B; Roupret M; Briganti A; Ploussard G; Breda A
    Eur Urol Oncol; 2023 Dec; 6(6):621-628. PubMed ID: 37634971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies.
    Wetterauer C; Federer-Gsponer JR; Leboutte FDJP; Mona R; Ebbing J; Rentsch CA; Manka L; Seifert HH; Wyler S; Recker F; Kwiatkowski M
    Urol Int; 2022; 106(1):83-89. PubMed ID: 34350895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted multiparametric magnetic resonance imaging/transrectal ultrasound-guided (mpMRI/TRUS) fusion prostate biopsy versus systematic random prostate biopsy: A comparative real-life study.
    Pham THN; Schulze-Hagen MF; Rahnama'i MS
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1962. PubMed ID: 38217298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
    Prendeville S; Gertner M; Maganti M; Pintilie M; Perlis N; Toi A; Evans AJ; Finelli A; van der Kwast TH; Ghai S
    J Urol; 2018 Jul; 200(1):104-113. PubMed ID: 29408568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of the PRECISION Trial Biopsy Strategy to a Contemporary Magnetic Resonance Imaging-Targeted Biopsy Cohort-How Many Clinically Significant Prostate Cancers are Missed?
    Feuer Z; Meng X; Rosenkrantz AB; Kasivisvanathan V; Moore CM; Huang R; Deng FM; Lepor H; Wysock JS; Huang WC; Taneja SS
    J Urol; 2021 Mar; 205(3):740-747. PubMed ID: 33026927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?
    Deniffel D; Salinas E; Ientilucci M; Evans AJ; Fleshner N; Ghai S; Hamilton R; Roberts A; Toi A; van der Kwast T; Zlotta A; Finelli A; Haider MA; Perlis N
    J Urol; 2020 Dec; 204(6):1187-1194. PubMed ID: 32496160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MRI-targeted prostate biopsy: the next step forward!
    Cata ED; Andras I; Telecan T; Tamas-Szora A; Coman RT; Stanca DV; Coman I; Crisan N
    Med Pharm Rep; 2021 Apr; 94(2):145-157. PubMed ID: 34013185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy.
    Punnen S; Stoyanova R; Kwon D; Reis IM; Soodana-Prakash N; Ritch CR; Nahar B; Gonzalgo ML; Kava B; Liu Y; Arora H; Gaston SM; Castillo Acosta RP; Pra AD; Abramowitz M; Kryvenko ON; Davicioni E; Pollack A; Parekh DJ
    J Urol; 2021 May; 205(5):1344-1351. PubMed ID: 33356482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.